Profiel
Ronald P.
Landbloom worked as an Associate Medical Director-Neuroscience at Eli Lilly & Co. from 2005 to 2006.
He then worked as Vice President-Medical & Regulatory Affairs at Orexigen Therapeutics, Inc. from 2006 to 2009.
Landbloom holds a doctorate degree from the University of Minnesota and an undergraduate degree from The University of New Mexico.
Eerdere bekende functies van Ronald P. Landbloom
| Bedrijven | Functie | Einde |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-10-2006 |
| OREXIGEN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Ronald P. Landbloom
| University of Minnesota | Doctorate Degree |
| The University of New Mexico | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
